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Abstract: Photocatalytic materials and semiconductors of appropriate structural and morphological 23 
architectures as well as energy band gaps are the materials needed for mitigating current 24 
environmental problems as these materials have the ability to exploit the full spectrum of solar light 25 
in a number of applications. Hence, constructing a Z-scheme heterojunction is an ideal approach to 26 
overcome the limitations of a single component or traditional heterogeneous catalysts for the 27 
competent removal of organic chemicals present in wastewater, to mention one of the areas of 28 
application.  A Z-scheme catalyst possesses many attributes, including enhanced light harvesting 29 
capacity, strong redox ability and different oxidation and reduction positions. In the present work, 30 
a novel ternary z-scheme photocatalyst, i.e. Bi2WO6/C-dots/TiO2, has been prepared by a facile 31 
chemical wet technique. The prepared solar light driven z-scheme composite was characterized by 32 
many  analytical and spectroscopic practices including  powder X-ray diffraction (XRD), field 33 
emission scanning electron microscopy (FE-SEM), N2 adsorption-desorption isotherm, Fourier-34 
transform infrared spectroscopy (FT-IR), photoluminescence (PL) and UV-vis diffuse reflectance 35 
spectroscopy (DRS). The photocatalytic activity of the Bi2WO6/C-dots/TiO2 composite was evaluated 36 
by studying the degradation of fluoroquinolone drug, levofloxacin under solar light irradiation. 37 
Almost complete (99%) decomposition of the levofloxacin drug was observed in 90 minutes of 38 
sunlight irradiation. The effect of catalyst loading, initial substrate concentration and pH of the 39 
reaction was also optimized. The photocatalytic activity of the prepared catalyst was also compared 40 
with that of bare Bi2WO6, TiO2 and TiO2/C-dots under optimized conditions. Scavenger radical trap 41 
studies and terephthalic acid (TPA) fluorescence technique were done to understand the role  of 42 
the photoinduced active radical ions that are bring about the  decomposition of levofloxacin. Based 43 
on these studies, the plausible degradation trail of levofloxacin was proposed and was further 44 
supported by LC-MS analysis. 45 
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1. Introduction 49 
The occurrence of  pharmaceuticals and personal care products (PPCPs) in environmental 50 
samples has been observed over the past few decades and these compounds are now considered as 51 
contaminants of emerging concern as these are biologically active even at low concentrations [1,2]. 52 
Pharmaceuticals have appeared as rapidly growing environmental contaminants and are one of the 53 
major concerns of national public health experts [3]. Hence, these substances have been called 54 
“pseudo-persistent” pollutants due to their unregulated and continuous discharge directly or 55 
indirectly to r water systems via number of ways [4]. A large amount of these compounds enter water  56 
bodies primarily from wastewater treatment plant effluents and other sources such as hospital 57 
discharge, inappropriate disposal by manufacturer  and from  expired and unused drugs [5]. Local 58 
release of pharmaceutical drugs may cause problems in aquatic environments since they are active  59 
at low concentrations ranging from ng/L-µg/L [6]. However, the consumption of few drugs is 60 
shockingly high. For instance, the antibiotics, the defined daily dose is quite high as compared to the 61 
dose defined by World Health Organization [7]. Levofloxacin is such an example of a broad spectrum 62 
fluoroquinolone antibiotic which is widely used as an antibacterial agent [8]. The high consumption 63 
of  fluoroquinolones drug and  its  poor disposal into water sources has resulted in a  generation 64 
of more toxic and  resistant fecal bacteria [9]. Conventional wastewater treatment plants are not 65 
designed for the complete elimination of these compounds owing to their resistance to 66 
biodegradation. P photocatalysis technique has emerged as promising technology and has garnered 67 
increased research attention [10,11]. Photocatalysts with broad absorption range, narrow band gap, 68 
high stability, efficient charge separation, high redox abilities can directly convert solar energy 69 
into storable energy compounds and degrade hazardous organic pollutants into least toxic 70 
compounds. Photocatalysts can also reduce CO2 to renewable fuels, such as ---?? [12-16]. However, 71 
a single  photocatalyst cannot possess all the ideal characteristics, for example,  wide absorption 72 
range and strong redox abilities are  difficult to achieve simultaneously in  a single 73 
photocatalyst [17]. These properties can be achieved by designing appropriate photocatalytic 74 
systems. In a heterojunction type photocatalytic system, two photocatalysts of dissimilar band 75 
gap values are involved, the photo-induced electrons from the conduction band (CB) of one 76 
photocatalyst (PC1) migrates to the CB of other photocatalyst (PC2) and photo-induced holes also 77 
migrate from the valence band (VB) of PC2 to VB of PC1, thereby leading to increased charge 78 
separation and reduced recombination of charge carriers. However, the redox capabilities of both 79 
photocatalysts are neglected as the oxidation and reduction processes are occurring on the 80 
semiconductors with the lower oxidation and reduction potentials, respectively. Hence, even if this 81 
heterogeneous photocatalytic system can hinder the recombination of photogenerated charge 82 
carriers, it cannot   possess efficient charge separation and the strong redox ability simultaneously 83 
[18,19]. To address these limitations calls an investigation of more efficient a photocatalytic systems. 84 
Artificial Z-scheme photocatalytic system can overcome the drawbacks associated with single 85 
component and heterojunction type photocatalyst systems. It mimics the photosynthesis process that 86 
includes a two-step photoexcitation. Like a heterojunction type photocatalytic system, it can also 87 
efficiently overcome the recombination of photogenerated charge carriers although in this case, 88 
strong redox abilities can also be achieved by combining two narrow band gap semiconductors. In 89 
the typical mechanism, the photogenerated electrons on CB of PCI do not migrate to PCII, making 90 
PCI electron rich region and thereby, obstruct the photo-oxidation of PCI and simultaneously making 91 
PCII a hole rich region which can cover PCII from photo-oxidation [20,21]. So, in the present work, a 92 
ternary z-scheme photocatalyst, (Bi2WO6/C-dots/TiO2), was synthesized by a facile surfactant free 93 
hydrothermal method. The synthesized catalyst was characterized by analytical and spectroscopic 94 
techniques and, further, its photocatalytic activity was tested against the decomposition of the 95 
antibiotic levofloxacin under sunlight. 96 
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 99 
2. Materials and Methods  100 
L-ascorbic acid (C6H8O6, < 99.0%), bismuth (III) nitrate pentahydrate (Bi(NO3)3.5H2O, 98.0%), sodium 101 
tungsten oxide dihydrate (Na2WO4.2H2O, 95.0%) and ethanol (C2H5OH) were bought from Alfa 102 
Aesar, United Kingdom, respectively. Terephthalic acid (TPA) (C8H6O4, 99.0%), sodium hydroxide 103 
(NaOH, 99.0%), formic acid (HCOOH, 99.0%), potassium iodide (KI, 99.0%) and titanium 104 
isopropoxide (TTIP, <99.0%) and were purchased from Sigma-Aldrich, India. bought from Merck, 105 
India. Fluoroquinolone drug levofloxacin was procured from Saurav Chemicals, Derabassi, India. 106 
Deionized water has been utilized for all experiments. 107 
 108 
2.2. Preparation of the catalysts 109 
2.2.1 Synthesis of Bi2WO6 110 
Bi2WO6 was synthesized by the hydrothermal method. In a brief process, 0.006 mol (1.455 g) of 111 
bismuth nitrate pentahydrate (Bi(NO3)3.5H2O) was solubilized in 37.5 mL of water, labelled as 112 
solution 1. 0.003 mol (0.5 g) of sodium tungstate dihydrate (Na2(WO4).2H2O) was dissolved in 12.5 113 
mL of ethylene glycol and labelled as solution 2. The latter was introduced into former under 114 
sonication with drop wise addition. The resultant sol was stirred for an hour and then transferred to 115 
a 75 mL Teflon-lined stainless steel autoclave for hydrothermal treatment at 1600C for 25 h. After the 116 
reaction, the precipitates were collected via centrifugation and washed with ethanol and water 117 
thoroughly and dried at 500C overnight. 118 
 119 
2.2.2 Synthesis of TiO2/C-dots 120 
TiO2 was synthesized by hydrothermal method with slight modifications from the previous work 121 
[22]. In this procedure, 6 mL of TTIP was added to 10 mL of ethanol and the mixture was stirred for 122 
30 minutes and designated as solution 1. Further, the equimolar concentrations of water and ethanol 123 
solution (50 mL) and named as solution 2.  Solution 2 was introduced into solution 1 slowly with 124 
constant stirring for 30 minutes. Immediate turbidity was seen in the solution after the addition. The 125 
turbid solution was then placed in Teflon lined stainless steel autoclave. Meanwhile, L-ascorbic acid 126 
(0.5 g), was dissolved into 50 mL of ethanol and kept under stirring and then it was transferred into 127 
the Teflon autoclave for hydrothermal treatment at 1800C for 4 h. The obtained precipitates were 128 
separated by centrifugation after the completion of hydrothermal reaction. The precipitates were 129 
carefully washed with the water and ethanol and kept for drying in oven at 600C. The colour of 130 
powder changed from clear white to pale white, specifying the successful synthesis of TiO2/C-dots. 131 
 132 
2.2.3 Synthesis of Bi2WO6/C-dots/TiO2 133 
Bismuth tungstate (0.5 g) and TiO2/C-dots (0.25 g) were dispersed in 25 mL of ethanol and kept under 134 
magnetic stirring overnight. The precipitates collected were then washed, filtered and dried at 500C 135 
overnight. 136 
 137 
2.3 Characterizations of prepared catalysts 138 
The crystallinity and structure analysis of the catalysts were determined by Powder X-ray diffraction 139 
using a PANalytical Empyrean X-ray diffractometer with Cu Kα1 radiation. Results were recorded 140 
using the instruments inbuilt software. The XRD patterns obtained were analysed using PANalytical 141 
Highscore Plus. Fourier Transformation Infra-red of the powder samples were recorded on Thermo 142 
Scientific Nicolet iS5 FTIR spectrometer (wavenumber range: 600-4000 cm-1). The surface morphology 143 
of the samples was analyzed using the Hitachi-SU8010 field-emission electron microscope (FE-SEM), 144 
operating at the voltage of 15 kV equipped with energy dispersive spectroscopy (EDS; Bruker 145 
XFlash). The thermogravimetric analysis (TGA) of the catalysts was performed on Perkin Elmer 146 
Simultaneous Thermal Analyzer (STA) 8000 in the temperature range300C to 8000C. The fluorescence 147 
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spectra of the samples were recorded on Cary Eclipse Fluorescence Spectrophotometer (Agilent 148 
Technologies). The UV-vis DRS spectra of the photocatalysts were obtained from Shimadzu UV-2600 149 
spectrophotometer with barium sulphate taken as a reference. The nitrogen adsorption and 150 
desorption isotherms of the prepared catalyst were measured using surface area analyser BELSORP, 151 
prior to the analysis, the samples were degassed at 1000C for 24 hours. The pore size distribution 152 
curve, total pore volume and mean pore diameter were determined from the desorption branch of 153 
Barrett- Joyner- Halenda (BJH) model. The absorbance of the samples was recorded on the Shimadzu 154 
UV-Vis spectrophotometer (UV-2600). The liquid chromatography–mass spectroscopy (LC-MS) of 155 
the drug samples was analysed on Agilent Technologies 6120 Quadrupole LC-MS to determine the 156 
degradation products formed and other intermediates. 157 
 158 
2.4 Photocatalytic experiments 159 
The photocatalytic experiments were carried out using antibiotic drug levofloxacin as a target 160 
pollutant and its degradation was observed under direct sunlight irradiation. The solar experiments 161 
were carried out under direct sunlight in a cylindrical slurry batch reactor with the average intensity 162 
of 70 Klux. In a typical photocatalytic test, different amounts of prepared photocatalyst was 163 
introduced in levofloxacin solution (100 mL, 10 mg/L) and kept under stirring in dark for 30 minutes 164 
for the achievement of adsorption-desorption process. The reaction solution was then subjected to 165 
solar light irradiation. The samples (2 mL) were drawn from the reaction at set time periods and made 166 
to pass via 0.22 µm Millex syringe filter. Other process parameters, i.e. catalyst dosage, pH and initial 167 
pollutant concentration were studied for the photocatalytic experiments. The % degradation can be 168 
determined from the equation given below: 169 
 170 
% degradation = 
𝑪𝟎−𝑪
𝑪
 𝑿 𝟏𝟎𝟎 171 
 172 
Where C0 and C are the initial drug concentration and concentration of drug at time t. 173 
 174 
2.5 Investigation of function of active radical ions in the decomposition of levofloxacin under 175 
sunlight illumination 176 
The generation of hydroxyl radicals from the sunlight illuminated Bi2WO6/C-dots/TiO2 was 177 
examined using a TPA fluorescence technique. The levofloxacin drug solution was replaced with 100 178 
mL of 0.5 mM TPA solution in 2 mM sodium hydroxide. The optimized dose of photocatalyst was 179 
added into the TPA solution and illuminated by direct sunlight under constant stirring and the 180 
samples were drawn from the respective solutions at pre-designed intervals. The aliquots were then 181 
made to pass through filter and the corresponding fluorescence spectra were obtained from PL 182 
spectrophotometer at λex=315 nm. Further, scavenger experiments were implemented to investigate 183 
the occurrence and character of active radical ions in the photocatalytic system. Potassium iodide (KI) 184 
and formic acid (HCOOH) of concentrations 0.01 M, were served as scavenger for holes (h+) and 185 
electrons (e-) in the reaction system. The quenchers were dispersed into the levofloxacin drug solution 186 
before the adding the catalyst and solar light illumination maintaining other optimized parameters 187 
constant, i.e., drug concentration, catalyst dose and pH of drug solution. 188 
3. Results and discussion 189 
3.1 Characterization of the synthesized catalysts  190 
The crystallinity, structural characteristics and purity analysis were studied by powder XRD 191 
technique. The powder XRD patterns of Bi2WO6, TiO2/C-dots and Bi2WO6/C-dots/TiO2 are displayed 192 
in Fig. 1. In the case of TiO2/C-dots, the well-known and sharp peaks at 2θ = 25.4, 38.10, 48.05, 53.80, 193 
55.11 and 62.81 were observed, that are corresponding to the pure anatase phase of TiO2, and the 194 
results were found to be in consistence with JCPDS card no. 21-1272 [22,23]. It was clear from the 195 
figure that no distinctive peak for C-dots around 200-240 was observed in the pattern which might be 196 
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due to reduced concentration of C-dots. The values of lattice constants ‘‘a’’ and ‘‘c’’ were 3.78 Å and 197 
9.44 Å, calculated from tetragonal crystal. In case of Bi2WO6, the diffraction peaks centered at 2θ= 198 
28.30°, 32.81°, 35.90°, 47.12°, 55.81°, 58.52°, 68.90°, 76.0° and 78.3° are attributed to  the orthorhombic 199 
phase of Bi2WO6  and are  in agreement with JCPDS card No. 39-0256 [24-27]. The values of lattice 200 
constants of Bi2WO6 were computed to be 5.456 Å (a), 5.454 Å (b) and 16.455 Å (c). In the XRD pattern 201 
of Bi2WO6/C-dots/TiO2, all the peaks belonging to Bi2WO6 and TiO2/C-dots were present, thereby 202 
confirming the successful synthesis of z-scheme catalyst. Narrow and sharp diffraction patterns 203 
confirmed the crystalline nature of the composite. The average crystallite size of the z-scheme 204 
photocatalyst was computed from Debye-Scherrer’s formula as given: 205 
 206 
D=0.94λ/βcosθ 207 
 208 
Where D is the crystallite size (average), λ is the wavelength of X-ray radiation, β is the 209 
broadening of the diffraction line assessed at full width half maxima value (FWHM) and θ is the 210 
Bragg’s angle. The crystallite size of the z-scheme catalyst (Bi2WO6/C-dots/TiO2) was computed to be 211 
34.29 nm. 212 
 213 
Fig. 1. XRD spectra of Bi2WO6 (#), TiO2/C-dots (*), and Bi2WO6/C-dots/TiO2. 214 
 215 
The morphologies of Bi2WO6 and Bi2WO6/C-dots/TiO2 were depicted with FESEM provided with 216 
EDS. Fig. 2 displays the FESEM and EDS analysis of Bi2WO6/C-dots/TiO2 z-scheme nano-217 
photocatalyst. In Fig. 2a, it can be seen that Bi2WO6 exhibited flakes like morphology of irregular size. 218 
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The edges of flakes were found to be asymmetrical and uneven, however the base and sides were 219 
found to be smooth (Fig. 2b).  220 
 221 
Fig. 2. (a-c) FESEM images of Bi2WO6/C-dots/TiO2 at different magnifications. (d) EDX of Bi2WO6/C-222 
dots/TiO2 223 
 224 
The nanoflakes were grown in high density and these were clustered together with each other 225 
in random fashion exhibiting high aspect ratio (Fig. 2c), whereas the nanoparticles of the TiO2/C-dots 226 
were embedded at the surface of flakes. EDS spectrum of Bi2WO6/C-dots/TiO2 displayed the presence 227 
of bismuth (Bi), titanium (Ti), tungstate (W), carbon (C) and oxygen (O) in the photocatalyst (Fig. 2d). 228 
The morphology of Bi2WO6 and TiO2/C-dots was also studied, Bi2WO6 also possessed nanoflakes 229 
morphology but the flakes were highly agglomerated in nature (Fig. S1 and S2). EDS spectrum of 230 
Bi2WO6 is given in supplementary information (Fig. S1) and its elemental composition is depicted in 231 
Table S1. 232 
 233 
Table 1. Elemental composition of Bi2WO6/C-dots/TiO2 234 
Element Series unn. C 
[wt.%] 
norm. C 
[wt.%] 
Atom. C 
[wt.%] 
Error (3 Sigma) 
[wt.%] 
Bismuth M-Series 17.10 14.74 5.10 1.98 
Carbon K-Series 6.61 5.70 34.33 4.22 
Oxygen K-Series 1.45 1.25 5.65 1.47 
Tungsten L-Series 65.80 56.73 22.32 7.86 
Titanium K-Series 25.03 21.58 32.60 2.37 
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 Total 115.99 100.00 100.00  
 235 
Further, the synthesis of z-scheme catalyst (Bi2WO6/C-dots/TiO2) was also confirmed by 236 
elemental mapping as shown in Fig. 3. The mapping outcomes concluded that elements concerned 237 
i.e., Bi, Ti, W and C and O were present in various proportions and quantity in the catalyst In 238 
summary, there was inhomogeneous contribution of elements in the catalyst carrier material. The 239 
elemental composition from EDS spectrum of sample is displayed in Table 1. 240 
 241 
Fig. 3 Elemental mapping of Bi2WO6/C-dots/TiO2 showing different colours for Bi, W, Ti, C and O 242 
 243 
FTIR spectroscopy revealed the presence of functional groups and other chemical composition 244 
of catalyst as shown in Fig 4a. The broad absorption curve in the region 3000-3400 cm−1 and sharp 245 
peak at 1620 cm−1 might be related to the bending and stretching modes of adsorbed water on the 246 
surface of catalyst [28,29]. The distinctive bands between 600–1000 cm−1 were attributed to W-O bond 247 
in terms of stretching and bridging modes. For instance, W-O stretching vibration was positioned at 248 
682 cm−1 and W-O-W bending vibrations modes were centered at 821 cm−1 and 1290 cm−1 [30,31]. 249 
Thermogravimetric analysis of Bi2WO6/C-dots/TiO2 and TiO2/C-dots presented the thermal 250 
properties of the synthesized catalysts (Fig. 4b). It was noticed that TiO2/C-dots showed 22.8% weight 251 
loss (initial weight: 3.506 g, weight loss: 0.8 g), whereas Bi2WO6/C-dots/TiO2 exhibited only 7.73% 252 
weight loss (initial weight: 4.306 g, weight loss: 0.33 g), in the temperature ranging from 300C to 8000C. 253 
The weight loss in both the cases was because of the desorption of adsorbed water from the surface 254 
of the catalysts and degradation of oxygen containing functional groups from the surface [32]. The z-255 
scheme nano-photocatalyst exhibited exceptionally high thermal stability throughout the whole 256 
temperature range. 257 
The optical characteristics of the synthesized z-scheme nanophotocatalyst were studied using 258 
the PL and UV-vis DRS. PL emission is directly related to the efficient separation of photoinduced 259 
charge transporters. PL spectra of Bi2WO6 and Bi2WO6/C-dots/ TiO2 were obtained at an excitation 260 
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wavelength of 360 nm (Fig. 4c). Bi2WO6 exhibited sharp peak at 421 nm ascribed to the higher 261 
probabilities of recombination of photoinduced charge transporters. Few PL emission bands in the 262 
wavelength area 450-500 nm were related to the blue-green emission band. On the other hand, in 263 
Bi2WO6/C-dots/TiO2, the PL intensity of sharp peak at 421 nm also got reduced, implying that there 264 
would be lesser recombination of photoinduced charge carriers. The outcome suggested that greater 265 
number of induced charge carriers would be available to participate in the photocatalytic mechanism. 266 
A broad and minor peak at 525 nm are related to metal atom/crystal defects owing to oxygen 267 
vacancies [33,34]. The absorption properties and band gap of Bi2WO6 and Bi2WO6/C-dots/TiO2 were 268 
determined by UV-vis DRS (Fig. 4d). The energy band gap of Bi2WO6 and Bi2WO6/C-dots/TiO2 was 269 
calculated using the equation   below: 270 
𝑬𝒈 =
𝟏𝟐𝟒𝟎
𝝀𝒎𝒂𝒙
 271 
where  Eg is  the calculated energy band gap (eV) and λmax is the observed wavelength 272 
calculated from the edge of absorption curve by drawing a tangent to it .  273 
 274 
 275 
Fig. 4 FTIR analysis of Bi2WO6 and Bi2WO6/C-dots/TiO2 (b) Thermogravimetric analysis of TiO2/C-276 
dots and Bi2WO6/C-dots/TiO2 (c) PL spectra of Bi2WO6 and Bi2WO6/C-dots/TiO2 at λex= 360 nm (d) 277 
UV-vis DRS analysis of Bi2WO6 and Bi2WO6/C-dots/TiO2.  278 
 279 
The maximum absorption edges of Bi2WO6 and Bi2WO6/C-dots/TiO2 were observed at the 450 280 
nm and 495 nm, and the corresponding values of Eg were estimated to be 2.75 eV and 2.50 eV. The 281 
lower value of the Eg indicated the enhanced light absorption ability of the Bi2WO6/C-dots/TiO2 and 282 
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similar for the photocatalytic degradation of levofloxacin by Bi2WO6/C-dots/TiO2 [33]. PL studies also 283 
supported the improved degradation of levofloxacin by Bi2WO6/C-dots/TiO2 under direct sunlight. 284 
The specific surface area of the composite gives an idea about the accessibility of active sites on 285 
the surface of catalyst, more the specific surface area of the catalyst, the more will be improvement in 286 
the charge movement of photoinduced charge carriers hence, enhanced photocatalytic activity. 287 
Brunauer–Emmett–Teller (BET) results measure the surface area of porous materials. N2 adsorption-288 
desorption isotherm and BJH pore size distribution curve of the synthesized Bi2WO6 and Bi2WO6/C-289 
dots/TiO2 z-scheme catalyst are shown in Fig. 5. The hysteresis loop for both Bi2WO6 and Bi2WO6/C-290 
dots/TiO2 z-scheme catalyst was of type-IV isotherm, representing typical mesoporous nature of 291 
nanostructures. The specific surface area of Bi2WO6 and Bi2WO6/C-dots/TiO2 was determined to be 292 
18.364 m2/g and 48.8 m2/g, respectively and total pore volume of Bi2WO6 and Bi2WO6/C-dots/TiO2 was 293 
computed to be 0.0309 cm3/g and 0.102 cm3/g, respectively. Hence, the increased specific surface area 294 
of the z-scheme catalyst, i.e. Bi2WO6/C-dots/TiO2 over bare Bi2WO6 also promise its enhanced 295 
degradation of levofloxacin drug under sunlight illumination. 296 
 297 
Fig. 5 N2 adsorption-desorption isotherm of (a) Bi2WO6 and (b) Bi2WO6/C-dots/TiO2. BJH curve 298 
displaying pore size distribution of (c) Bi2WO6 and (d) Bi2WO6/C-dots/TiO2. 299 
 300 
3.2. Photocatalytic activity of z-scheme nano-photocatalyst under solar light illumination. 301 
The photocatalytic efficiency of the synthesized catalysts was tested by observing the 302 
decomposition of levofloxacin (fluoroquinolone drug; colorless pollutant). Antibiotic levofloxacin 303 
showed the absorbance maximum at λmax=286 nm. Time dependent UV-vis absorbance spectra of the 304 
levofloxacin is demonstrated in Fig 6a. The absorbance of the levofloxacin drug solution (10 mg/L) 305 
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tend to diminish with increase in reaction time in the existence of the Bi2WO6/C-dots/TiO2 under 306 
sunlight. The absolute degradation of the levofloxacin drug was achieved in 90 minutes of sunlight 307 
irradiation with 0.075 g/L dose of z-scheme catalyst (Bi2WO6/C-dots/TiO2)’ at pH 7 of drug solution 308 
(Fig. 6a). Likewise, the degradation of the levofloxacin was monitored without the catalyst, however 309 
under solar light illumination, process commonly known as photolysis and there was no degradation 310 
observed in the case, thus photolysis proved incompetent for the decomposition of levofloxacin drug 311 
(Fig. 6b). However, 28% degradation of drug was obtained with catalyst (0.075 g/L) in 90 minutes 312 
under dark conditions (Fig. 6b). Therefore, it came to the revelation that the combination of light and 313 
presence of catalyst is mandatory for the efficient degradation of organic contaminants in aqueous 314 
medium.  315 
The photocatalytic efficiency of the z-scheme catalyst was also compared with bare Bi2WO6 and 316 
TiO2/C-dots under the same augmented and operating conditions. Bi2WO6 exhibited 88.3% 317 
degradation, whereas TiO2/C-dots showed 87.24% degradation of levofloxacin with same catalyst 318 
dose after 90 minutes of photocatalytic reaction (Fig 6b). The similar percentage of degradation of 319 
both the catalysts might be due to their almost similar Eg values calculated from UV-vis DRS studies.  320 
The impact of catalyst dose was studied to optimize the amount of catalyst usage in the 321 
photocatalytic reaction. The catalyst (Bi2WO6/C-dots/TiO2) dose was differed from 0.05 g/L to 0.25 g/L, 322 
while maintaining critical factors constant, i.e. initial substrate concentration (10 mg/L) and pH of 323 
drug solution to be 7 (neutral). Since the catalyst dose was raised from 0.05 g/L to 0.075 g/L, the 324 
degradation of levofloxacin was also observed to increase from 97% to 99% with Bi2WO6/C-dots/TiO2, 325 
however, the further rise in catalyst dose from 0.075 g/L to 0.1 g/L, resulted in a decrease in the 326 
degradation of levofloxacin to 88.7% and at a further increase in catalyst dose to 0.25 g/L, the 327 
degradation dropped to 82.58%. It indicated that any further increments in catalyst dose did not bring 328 
significant or enhanced degradation. The enhancement in photocatalytic activity with increased 329 
catalyst dose is attributed to the accessibility of a greater number of active sites on the surface of the 330 
Bi2WO6/C-dots/TiO2 and when catalyst dose was increased above 0.075 g/L, the photocatalytic 331 
decomposition of levofloxacin drug decreased   because of the shielding effect caused by 332 
nanoparticles at increased catalyst doses. This phenomenon explains the masking effect at the surface 333 
of the catalyst from illumination, hence obstructing the photons from reaching the substrate 334 
(levofloxacin). In other terms, the increased turbidity in the drug solution due to the presence of 335 
higher doses of catalyst led to fewer photon penetration and ultimately, the unwanted scattering of 336 
photons [36].  The pH of the levofloxacin was also changed from 5 to 9 to optimize the reaction 337 
parameters, while maintaining catalyst dose (0.075 g/L) and initial drug concentration of drug 338 
solution (10 ppm) constant. The maximum degradation of drug was achieved at neutral pH (7), i.e. 339 
99% and 89.4% and 90% of the degradation was achieved at pH 5 and 9, respectively. The variation 340 
in the results might be corresponding to the surface charge of the catalyst. 341 
The initial drug concentration was also varied from 5 mg/L to 20 mg/L. Different concentrations 342 
of the drug solution were made by diluting the stock solution (20 mg/L). With the increase in 343 
levofloxacin drug concentration, the photocatalytic degradation of drug gradually decreased. The 344 
performance of the catalyst was predominantly dependent on the concentration of pollutant. Since, 345 
increased concentration of organic pollutant would lead to the reduced formation of oxidizing species 346 
and the active sites over the catalyst surface would be captured by drug (substrate), and hence lower 347 
degradation [35].  348 
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 349 
 350 
Fig. 6 (a) Time dependent UV-vis absorbance spectra of levofloxacin (10 mg/L, pH 7) under sunlight  351 
with Bi2WO6/C-dots/TiO2 (0.075 g/L) (b) Assesment of photolysis, adsorption and photocatalytic 352 
efficiency of Bi2WO6/C-dots/TiO2 with bare Bi2WO6 and TiO2/C-dots (catalyst dose 0.075 g/L, pH 7, 353 
Conc. of drug 10 mg/L (c) Effect of variation in catalyst dose (Bi2WO6/C-dots/TiO2) on photocatalytic 354 
degradation of drug (d) Effect of change in pH of levofloxacin solution on photocatalytic behaviour 355 
of Bi2WO6/C-dots/TiO2 (dose 0.075 g/L) under sunlight 356 
 357 
 358 
The recyclability of the z-scheme catalyst was also carried out to examine its chemical stability 359 
for up to 4 cycles. For each consecutive cycle, the catalyst was separated from the reaction mixture by 360 
centrifugation, washed thoroughly with mixture of ethanol and distilled water (till the pH of 361 
supernatant is neutral) and dried in oven at 800C. The percentage degradation of levofloxacin for 362 
three cycles was calculated to be 99%, 95% and 92% indicating that the ternary z-scheme catalyst can 363 
be used efficiently as a reusable catalyst and thermal and mechanical stability could also be expected. 364 
 365 
 366 
 367 
 368 
 369 
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 370 
Fig. 7 (a) Influence of initial concentration of drug on the degradation of levofloxacin (b) No. of 371 
consecutive runs depicting recyclability of Bi2WO6/C-dots/TiO2 (c) Influence of scavengers on the 372 
photocatalytic activity of catalyst (drug conc. 10 ppm, pH 7, catalyst (Bi2WO6/C-dots/TiO2) dosage 373 
0.075 g/L) (d) PL spectra of TPA in presence of catalyst (Bi2WO6/C-dots/TiO2) at λex=315 nm. 374 
 375 
3.3. Probable mechanism for levofloxacin degradation with z-scheme catalyst under solar light 376 
irradiation 377 
The CB and VB potentials of Bi2WO6 and TiO2 were computed from the calculations based on 378 
UV-DRS studies and also by employing following equations: 379 
 380 
EVB= Xe- Ee + 0.5 Eg 381 
ECB= EVB - Eg 382 
 383 
Where EVB and ECB represent the valence and conduction band edge potentials. Ee represents the 384 
energy of free electrons on hydrogen scale, i.e. 4.5 eV. Eg calculated from UV- vis DRS studies for 385 
Bi2WO6, TiO2/C-dots and Bi2WO6/C-dots/TiO2 are 2.75 eV, 2.87 eV and 2.50 eV, respectively. Further 386 
EVB and ECB of Bi2WO6 were calculated to 3.2eV and 0.59 eV, and for TiO2/C-dots, the corresponding 387 
values are 2.8 eV and -0.21 eV, respectively. Depending upon the similar energy band gap values of 388 
Bi2WO6 and TiO2, two probable charge transfer mechanisms can be derived: traditional type II 389 
(double charge transfer) and z-scheme heterojunction (multiple charge transfer) mechanisms. If the 390 
transfer mechanism follows the double charge transfer theory, the photoinduced  e+ on the CB of 391 
TiO2 would likely transfer to the CB of Bi2WO6 and the h+ on the VB of Bi2WO6 would migrate to the 392 
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VB of TiO2 because the VB and CB potentials of Bi2WO6 are all lower than that of TiO2, respectively. 393 
However, the e+ on the CB of Bi2WO6 can’t reduce O2 to generate •O2− because the CB potential of 394 
Bi2WO6 (0.595 eV/vs. NHE) is lower than the standard redox potential of O2/•O2− (−0.046 eV vs. NHE). 395 
Similarly, h+ on the VB of TiO2 (2.8 eV vs. NHE) also cannot be efficiently oxidize H2O to yield •OH 396 
owing to the almost same redox potential of H2O/•OH with 2.73 eV vs. NHE.  397 
So in order to completely understand the degradation mechanism of antibiotic drug 398 
levofloxacin, multiple charge transfer mechanisms have to be followed. When Bi2WO6/C-dots/TiO2 is 399 
illuminated by solar light irradiation, the e- on CB of Bi2WO6 and h+ on the VB of TiO2 recombined 400 
with itself to form an inner heterojunction, nevertheless, the separated e- and h+ aggregate on CB of 401 
TiO2 and VB of Bi2WO6, respectively. Meanwhile C-dots on the surface of TiO2 accept as electron 402 
reservoir. Owing to the upconverted photoluminescence of C-dots, longer wavelength light could be 403 
converted into 350–650 nm light (shorter wavelength). Then, Bi2WO6 and TiO2, can competently 404 
consume the upconverted UV (from C-dots) and visible light, and hence the e—-h+ pairs were 405 
produced on the surface of Bi2WO6 and TiO2. Moreover, due to the z-scheme heterojunction between 406 
Bi2WO6 and TiO2, photoinduced e- in the CB of Bi2WO6 moved quickly into the VB of TiO2 and paired 407 
with the h+, thereby leading to the buildup of e- in the CB of TiO2 and h+ in the VB of Bi2WO6. Also, 408 
the increased number of e- in the TiO2 could be hence moved and gathered within C-dots. Afterwards, 409 
the e- could be reacted to adsorbed O2 to form superoxide radicals (O2 −). In the meantime, the h+ in 410 
the VB of Bi2WO6 could oxidize OH-/H2O to form .OH or participate in the degradation of organic 411 
pollutants [37,38]. Therefore, it is considered that Bi2WO6/C-dots/TiO2 composite could follow the z-412 
scheme charge transfer mechanism.  413 
Scavenger radical studies also confirmed the formation of holes and electrons in the 414 
photocatalytic reaction mechanism. The photocatalytic degradation of levofloxacin was observed to 415 
significantly decreased from 99% to 43% and 35% in the presence of HCOOH (quencher for electrons) 416 
and KI (quencher for holes), respectively (Fig. 7c). Hence, it was proven that the e- and h+ have a 417 
pivotal part to play in the degradation of levofloxacin. The formation of hydroxyl radicals in the 418 
photocatalytic reaction was determined by the TPA fluorescence process. TPA has tendency to 419 
transform itself into a fluorescent compound, i.e. 2-hydroxyterephthalic acid, on encountering 420 
photogenerated .OH. So, it is presumed that the production of hydroxyl radical species in the system 421 
was proportional to the PL emission intensity of 2-hydroxyterephthalic acid. It could be seen in Fig. 422 
7d, that the intensity of PL emission progressively rose under solar light irradiation with z-scheme 423 
photocatalyst. Hence, it is suggested that hydroxyl radicals were formed throughout the production 424 
of 2-hydroxyterephthalic acid and, thus, have a key role in the degradation of levofloxacin This 425 
compound was also observed to support the proposed mechanism of the photocatalytic process. Fig. 426 
8 represents the diagrammatic illustration of the photocatalytic degradation mechanism of 427 
levofloxacin with Bi2WO6/C-dots/TiO2 under sunlight irradiation. 428 
 429 
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 430 
Fig. 8 Plausible mechanism of photocatalytic degradation of levofloxacin with z-scheme 431 
photocatalyst. 432 
 433 
3.4 Investigation of degradation intermediates formed in the photocatalytic degradation of 434 
levofloxacin 435 
Attempts were made to elucidate the reaction intermediates composed during and after the 436 
photocatalytic degradation of levofloxacin at different time intervals and the plausible degradation 437 
pathway was constructed through identification of the levofloxacin and its derivatives or 438 
intermediates from LC-MS analysis based on the consideration of molecular ion peaks [M+H]+. 439 
Levofloxacin has the molecular formula (M=361.38 g/mol) according to its chemical formula 440 
C18H20FN3O4, and exhibited a protonated molecular peak at m/z=362 [22]. In addition to the 441 
protonated peak of lexofloxacin, fewer  intermediates were observed in MS spectra of the 442 
levofloxacin samples withdrawn at  time periods with the protonated peaks at m/z=392, 249, 282, 209 443 
and 101, respectively. The mass spectrograms are provided in Fig. S3 of supporting information. The 444 
ring-opening or de-methylation at the N1 and N4 position, followed by further oxidation via 445 
hydroxyl radicals led to the formation of intermediate at m/z=392 [35]. A fragment at m/z=346 might 446 
has been originated from the levofloxacin due to the loss of methyl group (-CH3). The as formed 447 
fragment underwent decarboxylation (-CO2) and leading   possibly to the formation of another 448 
intermediate with m/z of 302. Consequently, with the loss of HF from the former intermediate, 449 
another mass fragment at m/z=282 was obtained. A further m/z=249 (intermediate) was formed when 450 
an intermediate with m/z=346 underwent a gross loss of moiety C5H10N2. Likewise, another 451 
intermediate at m/z=263 might be obtained by the ring opening of the morpholine moiety at m/z=279 452 
and underwent dehydrations with loss of H2O, revealed by the presence of the intermediate at 453 
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m/z=209 [39]. N-methyl piperazine with m/z value of 101 was derived from the levofloxacin with the 454 
cleavage of piperazinyl substituent [40]. 455 
 456 
 457 
Fig. 9 Identification of degradation intermediates formed during the photocatalytic reaction. 458 
 459 
The kinetics of the photocatalytic degradation of levofloxacin was studied by Langmuir 460 
Hinshelwood kinetic model using the given equation 461 
ln(C0/C)=kt 462 
where C0 and C are the initial and final concentration of the drug solution, k is the rate constant 463 
and can be calculated from slope of the reaction and t is the time interval of the photocatalytic 464 
reaction.  465 
 466 
Table 2. Kinetics data of photocatalytic reaction of levofloxacin with different catalysts 467 
S. No. Photocatalyst Rate Constant (min-1) R2 
1 Bi2WO6/C-dots/TiO2 0.01831 0.99411 
2 Bi2WO6 0.01767 0.9977 
3 TiO2/C-dots 0.01713 0.99494 
 468 
The degradation of drug obeyed pseudo first order kinetics with all photocatalysts with different 469 
values of co-relation values (Fig. 10). Other significant details are shown in tabular form (Table 2). 470 
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 471 
Fig. 10 Graph of ln(C0/C) against time depicting kinetics of photocatalytic reaction. 472 
 473 
 474 
4. Conclusions 475 
A novel ternary z-scheme catalyst Bi2WO6/C-dots/TiO2 was successfully fabricated by ultrasonic 476 
assisted hydrothermal method and characterized by a number of techniques. The crystallite size of 477 
the catalyst was found to be 34.29 nm from powder XRD studies. FESEM images explained that 478 
Bi2WO6 exhibited nanoflakes like morphology that aggregated to form nanosheets, while 479 
nanoparticles of TiO2/C-dots were found to be assembled over the surface of nanoflakes. PL studies 480 
emphasized the optical properties of Bi2WO6/C-dots/TiO2, indicating the hindrance in the 481 
recombination of photo-induced charge transporters in z-scheme catalyst over bare Bi2WO6, 482 
suggesting that z-scheme catalyst could enhance the photocatalytic activity. This hypothesis is 483 
supported by UV-DRs studies which showed that the z-scheme catalyst has a lower band gap, i.e. 484 
2.50 eV compared to Bi2WO6 (2.75 eV) and TiO2/C-dots (2.87 eV). This suggests that Bi2WO6/C-485 
dots/TiO2 can be considered as efficient potential photocatalyst in the visible region of the solar 486 
spectrum. The photocatalytic behaviour of the synthesized catalysts was investigated by monitoring 487 
the degradation of fluoroquinolone levofloxacin drug under 90 minutes of sunlight illumination. 488 
Almost complete degradation was observed with Bi2WO6/C-dots/TiO2, whereas 88.3% and 87.24% 489 
degradation with Bi2WO6 and TiO2/C-dots under similar reaction conditions. The higher specific 490 
surface area of Bi2WO6/C-dots/TiO2 compared to bare Bi2WO6 calculated from nitrogen adsorption 491 
desorption isotherm, also showed that the z-scheme catalyst would provide more surface for the 492 
adsorption of the drug molecules and hence, improved photocatalytic activity.  Experimental 493 
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parameters including catalyst dose, reaction time, pH of drug solution and initial drug concentration 494 
were studied to optimize the photocatalytic reaction. A plausible mechanism for the degradation of 495 
the drug was also proposed based on scavenger radical trap experiments and TPA fluorescence 496 
technique. LC-MS analysis showed intermediates and other products at different stages of the 497 
photocatalytic process.  498 
 499 
Supplementary Materials: The following are available online at www.mdpi.com/xxx/s1, Figure S1: (a,b,c) 500 
FESEM images of Bi2WO6  at different magnifications. (d) EDS spectrum of Bi2WO6; Figure S2: TEM image of 501 
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